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A  variety  of  anti-polynucleofide antibodies  directed  against  native  DNA 
[NDNA] 1 (1-3),  single-stranded DNA  [SDNA]  (4-6),  double-stranded RNA 
[DSRNA]  (7-9),  polyribonucleotides  (10),  ribonucleoprotein  derived  from 
thymic nuclear extracts (11), and ribosomes (12) have been detected in human 
sera. Each of these antibodies is characteristically found at high levels in the 
sera  of  patients  with  systemic lupus  erythematosus  (SLE),  and  except  for 
anti-NDNA antibodies, they also have been observed in the sera of patients 
with a variety of diseases associated with active tissue destruction (8). Experi- 
mental studies indicate that an appropriate immunogen may induce antibodies 
to SDNA (13,  14), DSRNA (15),  polyribonucleotides (16, 17), and ribosomes 
(18),  but not to NDNA. Anti-NDNA antibodies are found only in the spon- 
taneous NZB/W  disease of mice  (19,  20).  These  observations indicate  that 
most polynucleotides are potentially immunogenic. 
Although it is known that antibodies to NDNA and SDNA are heterogeneous, 
the  cross-reacting specificities  and  the  interrelationship  of  these  antibodies 
in human sera have not been defined. Less information is available concerning 
the specificities of antibodies directed against DSRNA and ribonucleoprotein 
and their cross-reactions with other polynucleotides. The major objective of 
the present study was to elicit information concerning the types of immunogens 
most likely responsible for inducing the formation of  the various  anti-poly- 
nucleotide antibodies found in human sera. 
Materials and Methods 
Polyaucleotides Employed .for Immunological  Tests.--Native calf thymus DNA (NDNA), 
Escherlchla coli DNA, Clostridium perfringens DNA and  salmon sperm DNA (Worthington 
* Supported  by U.S. Public Health Service Grants AM 04761 and AM 13721. 
1 Abbreviations used in this paper: anti-A,  rabbit  anti-adenosine-bovine  albumin;  anti-T, 
rabbit  anti-thymidine-bovine albumin;  DSRNA, double-stranded  RNA; FTRBC, formalin- 
ized  O Rh positive  tanned  red  blood cells; ME,  mercaptoethanol;  NDNA, native DNA; 
PBS,  phosphate-buffered  saline; RBC, red blood cells; SDNA,  single-stranded  DNA; SLE, 
systemic lupus erythematosus;  UVDNA, ultraviolet irradiated  DNA. 
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Biochemical Corp., Freehold, N. J.), and Micrococcus lysodeikticus DNA (Miles Laboratories, 
Inc., Elkhart, Ind.). Poly A, Poly U, Poly G, Poly C, Poly A.Poly U, and Poly I.Poly C 
(Miles Laboratories, Inc.).  Poly dA,  Poly dT,  Poly dG,  and Poly  dC  (Biopolymers, Inc., 
Chagrin Falls, Ohio). 
Native SV 40 DNA was generously supplied  by Dr.  R.  Klett.  Adenovlrus 2  DNA and 
T4 phage DNA were generously supplied by Dr. W. Doerfler and Dr. W. Schweiger, respec- 
tively. Ultraviolet irradiated DNA (UVDNA) was prepared following the method of Tan et 
al. (21). Denatured DNA was prepared by heating native DNA at 100°C for 10 rain and trans- 
ferring directly to an ice bath. 
Ribosomes were prepared from cytoplasmic supernatant of Krebs ascites tumor cells (22) 
by centrifugation at 100,000g for 1 hr. The cytoplasmic supernatant was kindly supplied by 
Dr. A. O. Pogo. 
Serum Specimens.--Human sera were obtained from patients with the following diseases: 
SLE  [from 60 patients], rheumatoid arthritis (32), chronic active hepatitis (43), procalnamide 
administration  2 (19), primary biliary cirrhosis  (20),  infectious mononucleosis  (20),  chronic 
glomerulonephritis (40), and carcinoma of the cervix (13). In addition, 280 normal sera and 65 
sera were obtained randomly from hospitalized patients with a variety of diseases. 
Rabbit  anti-sera were  prepared  to  adenosine-bovine albumin  (anti-A)  and  thymidine- 
bovine albumin (anti-T) conjugates (13). The following polynucleotides were complexed to 
methyiated bovine serum albumin (14) in the proportion of 1 mg of polynucleotide to 1 mg of 
albumin  and  emulsified  in  complete  Freund's  adjuvant  before  immunization of  rabbits: 
NDNA, SDNA, Poly A-Poly U, Poly I.Poly C, and UVDNA. Two rabbits were immunized 
with each antigen. Serial serum specimens were obtained from 25 patients with SLE studied 
for periods of 6 months to 4 yr. 
_Procedures.--Actinomycin-labeled DNA was prepared and utilized in a  gamma globulin- 
binding assay as previously described (23). The amount of labeled DNA bound to red blood 
cells (RBC) was determined by solubilizing RBC from 1 cc of a 4c~ suspension in NCS reagent 
(Amersham-Searle Corp.,  Des  Plaines,  Ill.)  and  decolorizing with a  saturated  solution of 
benzoyl peroxide. Agar gel diffusion was performed in 0.6% agarose at pH 7.4 using well sizes 
as previously described (24). 
Hemagglutination tests employed formalinized O  Rh positive red blood cells (25)  which 
were tanned  (26)  [FTRBC] and incubated with polynucleotide antigens. Equal volumes of 
antigen in McIlvalne's buffer and a  3% suspension of FTRBC were used. Optimal time for 
incubation, pH of the buffer system, and concentration of the antigen were determined for 
each  system.  The  amount  of  tritiated  actinomycin-labeled NDNA  and  SDNA  bound  to 
FTRBC with different buffer systems and incubation times is shown in Table I. 
Antigen concentrations of  50 /zg/ml were used for NDNA  and UVDNA.  SDNA coats 
autoagglutinate at these concentrations, and therefore, lower concentration (10 #g/ml) of the 
aetinomycin-complexed form of SDNA was used  (23).  Poly A.Poly U, Poly I.Poly C, and 
Poly A were incubated with cells at 20 #g/ml. All coats were incubated for 60 min except for 
SDNA which was incubated for 15 min. 
Human and rabbit sera were inactivated for 30 rain at 56°C.  A  1:4 dilution of 0,2 cc of 
serum was diluted serially with 1% normal rabbit serum in pH 7.2, 0.02 M phosphate-buffered 
saline (PBS) and 0.1  cc PBS was added to each tube for a  total of 0.3 cc.  1 drop  (0.05 cc) 
of a 3% suspension of coated cells was added to each tube. The settling pattern was read after 
2 hr. 
The specificity of the hemagglutination reaction was determined by inhibition of the he- 
magglutination reaction with appropriate antigen. Before serial dilution of the test serum, 
0.1 cc of antigen was substituted for the PBS added to the first tube. The specificity of the 
NDNA coat was determined by the absence of reactivity of NDNA-eoated cells with rabbit 
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antisera (anti-T, anti-A, and anti-SDNA) and with two SLE sera containing antibodies reac- 
tive with SDNA. Antibodies to SDNA were assayed by prior adsorption of sera with NDNA 
so that all reactivity with NDNA-coated cells was eliminated. 
Quantitative inhibition studies were performed with an end point dilution of antiserum 
added to a serial dilution of antigen. The tube at which no significant inhibition of hemagglu- 
tination occurred was considered maximal inhibition by antigen in terms of  micrograms per 
milliliter or nanograms per milliliter.  The test  was used to quantitate and compare the in- 
hibitory activity of different polynucleotides with both human and rabbit antisera. 
Soluble saline extract of calf thymus nuclei was prepared as previously described (27) and 
coated on fresh human type O Rh positive tanned red blood cells for assay of anti-ribonucleo- 
protein antibodies. 
TABLE  I 
Binding of Native DNA and Single-Stranded DNA to Formalinized, Tanned RBC 
Amount bound to  Antigen incubation  Buffer system  Time of incubation  1 cc of 4% RBC 
(pH)  (rain)  q~g) 
SDNA (10 #g)  4.7  5  1.5 
15  4.9 
30  6.0 
60  5.9 
DNA (50 #g)  4.9  5  4.5 
15  6.0 
30  7.5 
60  7.0 
7.2  60  1.7 
4.9*  60  3.4 
DNA (10/zg)  4.9  5  1.9 
15  2.1 
30  2.7 
60  3.6 
* Formalinized only. 
Enzymatic treatments: Ribonuclease incubation of nuclear extract containing ribonucleo- 
protein was performed as previously described (24). Protease conjugated to  carboxymethyl- 
cellulose  (Enzite-Pro, Miles Laboratories, Inc.) was hydrated at 37°C for 1 hr and  incubated 
with nuclear extract for 1 hr at 37°C with agitation, in  ratio of 1 mg of Enzite-Pro to 2 mg 
of protein. 
Mercaptoethano[ treatment was performed on  selected sera by treating serum with 0.2 
mercaptoethanol for 1 hr at  37°C.  DEAE-column chromatography was performed for the 
isolation of fractions containing Sm antigen (28). A linear 10-40% sucrose gradient in pH 7.2 
phosphate-buffered saline was performed for separation of 7S and 19S gamma globulins. 
RESULTS 
Specificities of Anli-Polynucleotide Antibodies 
Sensitivity  of  Test  Syslems.--Sera  with  precipitin  reactions  with  NDNA 
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glutination assay was less  sensitive than the DNA-binding test for detecting 
anti-NDNA antibodies in sera without precipitins. 17 of 24 of these sera showed 
reaction with labeled DNA whereas 9 of 24 showed positive hemagglutination 
reactions. Such sera,  with negative hemagglutination tests,  had low levels of 
DNA-binding,  between  10  and  20%.  Several  sera  showed  greater  hemng- 
glutinating  activity than  DNA-binding.  A  comparison of the  results  of the 
hemagglutination test and DNA-binding assay for individual sera is shown in 
Fig. 1. 
Anti-NDNA  and  Anti-SDNA  Antibodies.--The  reactivity of  anti-NDNA 
antibodies  with  NDNA,  denatured DNA,  and various  synthetic polydeoxy- 
ribonucleotides  was  studied  primarily  with  the  hemagglutination-inhibition 
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Fro. 1. Comparison of % actinomycin-labeled  DNA precipitated by (NH4)2S04  and  he- 
magglutination titers of 47 SLE sera. 
system using NDNA as the red cell coat. Single-stranded DNA inhibited this 
system equally as well or better than NDNA in 16 of 17 sera tested (Table II). 
One serum (UH)  showed stronger reaction with NDNA. Less reactivity with 
polydeoxyribonucleotides was  demonstrated. Poly dA was  the most reactive 
nucleotide with anti-NDNA  antibody-coated cells,  whereas dT,  dG,  and dC 
were less reactive. In contrast, polyribonucleotides, both single- and double- 
stranded (Poly A, Poly G, Poly C, Poly U, Poly A.Poly U, and Poly I.Poly 
C) were unreactive with anti-NDNA antibodies in this system. 
No clear differences in reactivity among bacterial, viral, salmon sperm, and 
mammalian  DNA were demonstrated  (Table III).  It was found that native 
circular SV 40 DNA did not react as well as native calf thymus DNA. After 
denaturation,  however,  SV  40  DNA  reacted  comparably  with  denatured 
mammalian  and bacterial DNA.  Glucosylated T4 phage DNA was  also  less 
reactive  only  before  denaturation.  No  correlation  between  the  guanosine- 298  ANTIBODIES  TO  POLYNUCLEOTIDES  IN  HUMAN  SERA 
cytosine  content  of  the  various  DNA  preparations  (29)  and  reactivity  with 
anti-NDNA  antibody was evident. 
The  specificity of antibodies reactive  with SDNA  was  studied primarily by 
agar  gel  diffusion  in  order  to  differentiate  antibodies reactive with individual 
bases  and with  common  determinants  between  NDNA  and  SDNA.  The  sera 
were divided into two groups, those giving precipitin reactions with SDNA  and 
those  giving  precipitin  reactions with both  SDNA  and  NDNA.  Both  groups 
of  sera gave  clear  precipitin reactions with different  synthetic polydeoxyribo- 
TABLE  II 
Hemaggtutinatlon-Inhlbition  Reactions of NDNA , SDNA , and Synthetic 
Polydeoxyribonucleotides  Using 17 Different SLE Sera 
NDNA  SDNA  dA  dC  dG  dT 
GS  312"  20  --3~  --  --  -- 
LM  625  312  2500  2500  --  1250 
MC  625  39  156  --  --  5000 
UH  1  625  2500  --  --  -- 
IS  625  156  .... 
SV  39  39  2500  --  --  -- 
JB  5000  312  .... 
BA  2500  39  625  39  1250  156 
BR  39  39  .... 
JB  312  5  2  --  --  -- 
EG  39  1  20  312  2500  1250 
PW  20  39  78  --  --  -- 
DS  625  625  156  --  --  -- 
AE  78  10  .... 
AH  2500  39 
EU  156  78 
DB  312  156 
* Minimal  concentration  of  antigen  (ng/ml)  inhibiting positive  hemagglutination  re- 
action between test serum and native DNA-coated cells. 
Represents no inhibition at 20,000 ng/ml. 
nucleotides (Table IV). Only four of the 26 sera showed no reactivity with any 
of  the polydeoxyribonucleotides  as  was  the  case for  the control  sera.  Several 
sera  showed  slight  spurring  of  SDNA  over  NDNA  or  NDNA  over  SDNA, 
but  no  serum  was  reactive  only  with  NDNA.  The  precipitin  reactions  with 
synthetic  polydeoxyribonucleotides  were  useful  in  defining  the  multiple 
specificities  of  antibodies  reactive  with  SDNA.  Antibodies  with  single-base 
specificities were  observed in  addition  to  antibodies directed  against determi- 
nants  common  to one or more polydeoxyribonucleotides  and SDNA. 
Two  sera  illustrating  several  specificities  are  shown  in  Fig.  2.  Serum  Ro 
(Fig.  2  A)  contained antibodies specific for dC  and dT.  The  weakening of  the 
dC  precipitin  reaction  after  absorption  with  dT  indicates  that  antibodies  re- KOFFLER~ CARR~ AGNELLO, THOBLIRN~ AND  KUNKEL  299 
TABLE  III 
Hemagglutination-lnhibition  Reactions  of Mammalian,  Bacterial,  Viral,  and  Salmon  Sperm 
DNA  Using Six Different Sera 
CT (native) 
CT (denatured) 
SV 40 (native) 
SV 40 (denatured) 
Ad. 2 (native) 
Ad. 2 (denatured) 
T4 phage (native) 
T4 phage (denatured) 
T4 phage (native) without glu- 
cose 
E. coli (native) 
E. coli (denatured) 
Cl. perf.  (native) 
Cl. perf.  (denatured) 
M. lys. (native) 
M. lys.  (denatured) 
Salmon testes (native) 
Sal. testes (denatured) 
UH 
312" 
5,000 
1 
1,250 
5,000 
2,500 
156 
625 
0,000 
1,250 
5,000 
5,000 
5,000 
312 
625 
JB 
312 
2O 
312 
625 
0,000 
625 
0,000 
0,000 
625 
625 
312 
78 
5,000 
1,250 
78 
39 
PW 
39 
78 
625 
39 
5 
<1 
156 
2 
<1 
156 
5 
312 
2 
156 
20 
1,250 
156 
AE 
2,500 
312 
2,150 
625 
.0,000 
5,000 
2,500 
5,000 
1,250 
1,250 
5,000 
5,000 
2,500 
5,000 
BA 
2,500 
39 
10,000 
10 
625 
10 
10,000 
39 
78 
312 
10 
39 
20 
312 
39 
625 
10 
EG 
39 
10 
1,250 
625 
156 
78 
5,000 
1,250 
156 
156 
78 
625 
156 
156 
20 
78 
39 
* Minimal  concentration of  antigen  (ng/ml)  inhibiting positive  hemagglutination  re- 
action between test serum and native DNA-coated cells. 
Represents no inhibition at 20,000 ng/ml. 
TABLE  IV 
The Reaction of SLE Sera Containing Precipitins to DNA with Polydeoxyribo- 
and Polyribonudeotides 
No. of  Polydeoxyribonucleotides  Polyribonucleofides 
Patients  dC  dT  dA  dG  rC  rU  rA  rG  rI 
Sera with precipitins to  1  +  +  -  --  + 
NDNA and SDNA  3  +  + 
3  +  --  -- 
4  --  + 
4  --  -- 
Sera with precipitins to  2  +  +  +  --  +  --  + 
SDNA only  1  +  +  + 
4  +  +  --  -- 
1  +  ...... 
3  --  +  --  --  -- 
Totals  26  15  18  2  0  0  0  2  0  4 
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FiG. 2 A. Studies on serum Ro. The lines formed with Poly dC and Poly dT show faint 
spurs through each other. Absorption with either polynucleotide removes reactivity with that 
polynucleotide and weakens but does not eliminate reactivity with the other. 
Fro. 2 B. Studies  on serum Pe. The line formed with Poly dT spurs over the line with 
Poly dC, and absorption with Poly dC removes only the line with Poly dC. Absorption with 
Poly dT removes all reactivity. 
active with common determinants on polydeoxyribonucleotides are also present. 
Absorption with both dC  and dT did not eliminate the reaction with NDNA 
or SDNA, indicating the presence of a third population of antibodies. A second 
serum,  Pe  (Fig.  2  B)  showed  one population  of  antibodies  specific for  dT;  a KOFFLER,  CARR,  AGNELLO,  THOBURN~  AND  KUNKEL  301 
second reactive with dT,  dC,  and SDNA;  and a  third reactive with dC  and 
SDNA. Absorption with dC eliminates the reactions with dC and weakens the 
precipitin reaction with  SDNA.  Absorption with  dT removes reactions with 
SDNA, dC, and dT. Another pattern was observed in a third serum (Go) which 
contained antibodies reactive with dC  and dT. Absorption with either elimi- 
nates reaction with both and with SDNA, but not with NDNA.  This serum 
contains antibodies to common determinants of single-stranded polydeoxyribo- 
nucleotides and to SDNA. 
Anti-DSRNA.--Antibodies  reacting with DSRNA have been demonstrated 
by agar gel diffusion and hemagglutination tests,  raising  the possibility that 
these antibodies were specific for the double-stranded conformations of RNA. 
Antibodies reactive with Poly A-Poly U,  however, were found to cross-react 
not only with Poly I-Poly C, but with Poly A and denatured DNA (Table V). 
Poly I.Poly C showed greatest cross-reactivity; Poly A  and denatured DNA 
TABLE  V 
Inhibition of Hemagglutination Reaction of Anti-Poly A .Poly  U Antibodies by Polynucleotides 
Inhibition 
Antigen 
Poly A.Poly U  Poly I.Poly C  SDNA  Poly A 
Complete  20"  11  5  8 
Partial  2  5  3  4 
None  0  6  14  10 
* Number of SLE sera. 
showed  less  cross-reactivity.  Most  sera  inhibited  by  denatured  DNA  were 
also inhibited by Poly A, whereas lack of inhibition by denatured DNA was 
usually accompanied by failure of Poly A to inhibit. Rabbit anti-sera, however, 
showed  greater  specificity  for  the  homologous  double-stranded  polyribo- 
nucleotide.  The  quantitation  of  the  inhibitory  activity  of  Poly A. Poly U, 
Poly I. Poly C,  Poly A,  and denatured DNA in selected human sera and in 
four rabbit sera is shown in Table VI. None of the human sera showed complete 
specificity for Poly A. Poly U or Poly I. Poly C, whereas three of the four rabbit 
sera exhibited considerably greater specificity for the homologous immunogen. 
Anti-Ribonucleoprotein.--Several  nuclear antigens have been identified in a 
soluble fraction obtained by extraction of nuclei with buffered saline solutions. 
The present study measured antibodies to an antigen which has been previously 
demonstrated to be active in a hemagglutination assay (11,  27). This antigen 
is  sensitive to ribonuclease and protease and  is distinct from another nuclear 
antigen, the Sm antigen, which is not sensitive to ribonuclease. Fractions ob- 
tained from DEAE-column chromatography which contain the Sm antigen do 302  ANTIBODIES  TO  POLYNUCLEOTIDES  IN  HUMAN  SERA 
not contain the ribonucleoprotein. Column isolated fractions containing the Sm 
antigen were not active in a direct hemagglutination assay system. 
Anti-ribonucleoprotein  antibodies  showed precipitin  reactions  with  nuclear 
extract  utilizing  agar gel diffusion.  Sm antigen  and ribonucleoprotein  showed 
independent  precipitin  lines with sara containing antibodies  to both antigens. 
Several  sara  which  had  high  hemagglutination  titers  (> 1:500,000)  of  anti- 
ribonucleoprotein  antibodies  exhibited  precipitin  reactions  only when  diluted 
to 1 : 50 or 1 : 100,  indicating that precipitins  were not observed when a  serum 
contained significant antibody excess. 
Hemagglutinating activity of anti-ribonucleoprotein  antibody was inhibited 
TABLE VI 
Quantitation of  Hemagglutina~ion-lnhibition Reaction of  Anti-Poly  A.Poly  U  Antibodies 
Inhibiting antigens 
Poly A  Poly I 
•  Poly U  .Poly C  SDNA  Poly A 
SLE sera 
BA  0.3*  0.15 
BR  0.7  0.7 
PW  6  6 
CA  3  -- 
PA  0.07  0.7 
Rabbit anti-sera 
Anti-Poly A-Poly U (331)  0.3  -- 
Anti-Poly A.Poly U (332)  0.07  -- 
Anti-Poly I. Poly C (333)  6  0.7 
Anti-Poly I. Poly C (334)  --  3 
--  12 
--  0.3 
25  3 
* Minimal  concentration  of  antigen  (#g/ml)  inhibiting  positive  hemagglutination  re- 
action between test serum and Poly A-Poly U-coated cells. 
Represents no inhibition at 100/zg/ml. 
by a ribonuclease-protease-sensitive  antigen obtained from nuclear extract.  In 
addition,  ribosomes isolated from cytoplasmic  supernatant were  reactive with 
these antibodies. NDNA, SDNA, Poly A. Poly U, Poly I. Poly C, Poly A, and 
nuclear fractions containing Sm antigen were not reactive with anti-ribonucleo- 
protein antibodies. 
Interrelationships  of Anti-Polynucleotide  Antibodies  in  Serial  Studies  of SLE 
Patients 
Antibodies to NDNA, SDNA, and DSRNA were found to appear some time 
during  the  course  of  SLE  in  most  patients  (Table  VII).  In  contrast,  anti- 
ribonucleoprotein antibodies were absent from eight of 25 serial studies.  Peaks 
of NDNA  antibody were usually correlated  with  episodes  of disease  activity 
and  serum  complement  depression.  High  titers  of anti-SDNA  and  anti-Poly KOFFLER~  CARR,  AGNELLO~  THOBURN~  AND  KUNKEL  303 
A-Poly U  antibodies  frequently  occurred during  periods  of clinical  activity, 
but rises in the titers of these antibodies also occurred during clinically quiescent 
periods.  Approximately  one-half  of  the  patients  with  anti-ribonucleoprotein 
antibodies showed no significant fluctuation of antibody titers, which persisted 
TABLE VII 
Serial Studies of 25 Patients with SLE 
Antibody 
Poly A  RNA Pr  DNA  SDNA  .Poly U 
All sera positive 
All sera negative 
Peaks of antibody activity 
3  3  2  7 
3  2  6  8 
19  20  17  10 
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Fio. 3. Two episodes of clinical activity associated with rises in anti-NDNA antibody titers. 
Steroid treatment was associated with a rapid decline in clinical symptoms with a concomitant 
decrease in anti-NDNA antibody.  Anti-SDNA antibodies persisted after clinical symptoms 
abated.  Anti-DSRNA antibodies appeared during a clinically quiescent period. Note the ab- 
sence of anti-ribonucleoprotein antibodies in all sera tested. 
in all sera tested. These antibodies did not disappear during periods of inactive 
disease or after steroid therapy. Two serial studies showing a  typical relation- 
ship between the antipolynucleotide antibodies and clinical activity are shown 
in  Figs.  3  and  4.  These  patients  illustrate  the  sporadic  persistence  of  anti- 
SDNA  and  anti-DSRNA  antibodies  during  clinically  quiescent  periods  and 
also demonstrate the concomitant rise in titer which may occur when the titer 304  ANTIBODIES  TO  POLYNUCLEOTIDES  IN  HUMAN  SERA 
of  anti-NDNA  antibodies  increases.  Anti-ribonucleoprotein  antibodies  were 
present  in  high  titer  throughout the  course of one patient  and  absent  from 
another. 
In three patients  with  classical SLE,  anti-NDNA antibodies  were  not ob- 
served.  In  one  patient  with  severe  renal  disease,  anti-NDNA,  SDNA,  and 
DSP,  NA antibodies were absent and anti-ribonucleoprotein antibodies persisted 
in high  titer.  A  second patient  with  renal  disease  did not have  anti-NDNA 
antibodies but did demonstrate antibodies to other polynucleotides. 
M.R. 
Clinical 
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DNA  I  N"I  
DNA 
M  M  J  S  N  J  M  M  J  S  N  F  A  J 
1968  1969  1970 
Fro. 4. Three episodes of clinical activity associated with rises in anti-NDNA antibody. 
The third clinical episode of activity shows parallel increases in SDNA, DSRNA, and NDNA 
antibody titers. Anti-DSRNA antibodies persist during quiescent periods. Note anti-ribo- 
nucleoprotein antibodies persist in high titer throughout the course of the disease. 
Distribution  of  Antibodies  to  Polynucleotides  in  Human  Sera  in  Different 
Conditions 
Antibodies to NDNA are mainly restricted  to patients  with  SLE, whereas 
antibodies  to  SDNA,  Poly A.Poly U,  and  Poly I-Poly C  are found in  sera 
obtained from patients with other diseases  (Table VIII). Antibodies to SDNA 
are present in most patients with SLE and are also present in high incidence 
in  individuals  treated  with  procainamide,  rheumatoid  arthritis,  infectious 
mononucleosis, and chronic active hepatitis. Antibodies reactive with DSRNA 
preparations  are present in lower incidence in diseases other than SLE. Anti- KO~'FLER,  CARR~  AGNELLO,  THOBURN,  AND  KUNKEL  305 
bodies  to ribonucleoprotein were  limited mainly to patients with  SLE,  rheu- 
matoid arthritis,  and mixed connective tissue disease. 
Antibodies reactive with Poly A were found in 14 of 60 SLE sera with a titer 
of 4.6  (log base 2). Inhibition of the reaction with Poly A  was present in all 
cases. Poly A-Poly U  inhibited equally as well as Poly A in 12 of the 14 sera 
tested. 
SLE sera were also studied for the presence of antibodies specific for UVDNA. 
11  sera obtained from patients  with  photosensitivity reactions  and 46  serial 
serum  specimens from six  patients  with  active  SLE  showed  no  evidence  of 
antibody  to  UVDNA.  Two  rabbit  anti-sera  prepared  to  UVDNA  used  as 
positive controls had titers of 1:160 and 1:320. The reaction of these sera was 
TABLE  VIII 
Incidence of Antibodies to Polynucleotldes 
Sera  Antibodies positive % 
No.  Source  tested  NDNA  SDNA  Poly A-Poly U Poly I.Poly C  RNA Pr 
SLE  60  60  (7.3)*  87.0  (5.1)  55.0  (5.3)  21.6  (5.0)  66.6  (12.0) 
Normal  110  0.3  (5.0):~  3.7  (4.0)  0  1.1  (4.0)  0 
Hospital§  65  0  16.8  (4.3)  7.7  (4.1)  9.2  (4.3)  3.1  (9.0) 
Procainamide  19  0  52.6  (4.5)  10.5  (6.0)  5.3  (7.0)  0 
Chronic active hepatitis  43  2,3  (3.0)  58.2  (5.1)  27.2  (6.0)[[  --  01[ 
Infectious mononucleosis  20  0  40.0  (5.2)  10.0  (4.0)  5.0  (4.0)  0 
Rheumatoid  arthritis¶  32  3.1  (3.0)  59.5  (5.5)  3.0  (5.0)  0  15.5  (10.0) 
Chronic glomerulo-  40  2,5  (4.0)  7.5  (4,6)  0  --  2.5  (9.0) 
nephritis 
Primary biliary cirrhosis  20  0  15.0  (3.6)  --  --  -- 
Carcinoma of cervix  13  0  0  0  0 
* Mean titer of group of serums expressed as log base 2,  shown in parenthesis. 
280 normal sera were tested. 
§ Random hospital serums obtained from patients with a variety of diseases. 
I] 11 sera were tested. 
¶  Two patients had clinical evidence of  mixed connective tissue disease in addition to rheumatoid arthritis. 
completely inhibited by UVDNA, minimally inhibited by SDNA, and showed 
no inhibition by NDNA. 
Characteristics of Anti-Polynucleotide  Antibodies 
Anti-DNA  antibodies  were  mainly mercaptoethanol  (ME)  insensitive.  Of 
18 sera tested,  six sera showed no change in titer,  10 showed a moderate de- 
crease, and the reactivity of two sera was eliminated by ME treatment. Sucrose 
gradient ultracentrifugation of one serum (MR) also demonstrated activity of 
anti-NDNA antibodies in both 19S and 7S fractions. In contrast, the titers of 
anfi-ribonucleoprotein  antibodies  were  unaffected  by  ME  treatment.  Anti- 
SDNA and anti-Poly A. Poly U  antibodies were predominantly ME sensitive. 
These sera showed a  marked decrease in  titer  or loss of reactivity following 
ME  treatment.  Several  high-titered  sera,  with  anti-SDNA  and  anti-Poly 
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indicating  that  certain  sera  contained  antibody  populations  unaffected  by 
incubation with ME. 
DISCUSSION 
Previous studies have demonstrated that anti-NDNA and SDNA antibodies 
are  heterogeneous  (30-33)  and  that  antibodies  with  specificity for both  the 
native conformations as well as exposed nucleotides of the denatured molecule 
are present  in  the  sera  of patients  with  SLE.  The present  studies  with  the 
hemagglutination-inhibition  system  have  permitted  a  broader  survey  and 
indicate  that  most  antibodies  reactive with  NDNA  react  equally  as well  or 
more  avidly with  SDNA.  Only  one  of  17  sera  tested  showed  predominant 
specificity for  the  double-stranded  conformation.  Similar  antibodies  reactive 
with NDNA have been described in the NZB/W mice with a disease similar to 
SLE (19, 20). They have not as yet been produced in rabbits after various types 
of immunization which result in antibodies specific for SDNA. The possibility 
is raised by the present experiments that in susceptible hosts, i.e. patients with 
SLE and NZB/W mice, some type of SDNA is the immunogen involved but 
that here antibodies reactive with NDNA are also produced. 
The  reaction  of  anti-NDNA  antibodies  with  intact  circular  SV  40  DNA 
indicates  that interaction  of antibodies  with NDNA  does not require  strand 
breaks  or  significant  denaturation  of  the  native molecule.  Although  NDNA 
preparations may contain  small amounts of SDNA  (34),  several experiments 
indicate that in the present experiments the SDNA was not responsible for the 
NDNA reactions. Rabbit anti-sera to SDNA determinants and SLE sera con- 
taining antibodies directed only against SDNA did not cause agglutination of 
NDNA-coated cells.  The weaker reactions with intact circular DNA were most 
probably related to a unique conformation, since the denatured strands reacted 
in a fashion similar to other types of DNA in the NDNA system. The reaction 
of mammalian, bacterial, viral, and salmon sperm DNA with DNA antibodies 
showed  a  variable  pattern.  Sera  reacting  more  strongly  with  SDNA  than 
NDNA usually exhibited similar reactions with several types of DNA. Although 
the guanosine-cytosine content  ranged widely for the various types of DNA, 
the antibodies were not able to distinguish  differences among the DNA sub- 
strates.  These  studies  indicate  that  neither  host  tissue,  bacterial,  nor viral 
nucleotides  have preferential reactivity with anti-NDNA  antibodies found in 
human sera. 
Precipitin tests with synthetic polydeoxyribonucleotides revealed antibodies 
with  base  specificity  in  addition  to  antibodies  reactive  with  determinants 
common to SDNA and polydeoxyribonucleotides, and to SDNA and NDNA. 
Inhibition  with  polydeoxyribonucleotides  of precipitin  and  hemagglutination 
reactions of one serum (Ro) failed to eliminate reactivity with NDNA, whereas 
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reaction with NDNA.  The reaction of another serum (Go) with NDNA  was 
not inhibited by Poly dT and dC, but did show elimination of the reaction with 
NDNA by absorption with SDNA. Hemagglutination inhibition also showed 
that  anti-NDNA  antibodies  had  more avid reaction with  SDNA  than  with 
polydeoxyribonucleotides. Therefore,  both  precipitin  and  hemagglutination 
inhibition tests indicate that SDNA contains determinants for most antibodies 
reactive with NDNA  and  that  synthetic polydeoxyribonucleotides, although 
showing many properties of SDNA, are not "complete" antigens either because 
a  unique  conformation or  nucleotide sequence is  needed for the  reaction of 
anti-DNA antibodies. 
Antibodies to DSRNA also exhibit marked heterogeneity in human sera in 
contrast to rabbit anti-sera which have predominant specificity for homologous 
double-stranded polyribonucleotides. Antibodies from human sera reactive with 
Poly A. Poly U  cross-react strongly with Poly I. Poly C  and Poly A  and less 
strongly with SDNA. A quantitative comparison of the inhibitory activity of 
double-stranded  polyribonucleotides,  Poly A,  and  denatured  DNA  for  five 
high-titered sera containing antibodies reactive with Poly A.Poly U  revealed 
only one serum which reacted preferentially with Poly A. Poly U. The strong 
reactivity with Poly A  suggests that certain antibodies reactive with double- 
stranded  polyribonucleotides  may be  induced  by  single-stranded  polyribo- 
nucleotides  and  lack  specificity for  the  double-stranded  conformation.  The 
antibodies reactive with DSRNA have analogies with anti-NDNA antibodies 
with respect to the reaction with single-stranded molecules. Further evidence 
for  this  hypothesis  is  derived from  the  observation  that  most  anti-Poly A 
antibodies are also reactive with Poly A. Poly U. In this study it was not possible 
to assess the contribution of the Poly U moiety of the double-stranded molecule 
because of the ease of degradation of this molecule by ribonuclease. It has been 
suggested that double-stranded RNA virus is responsible for stimulating  the 
formation of antibodies reactive with synthetic DSRNA  (7). The lack of re- 
activity with transfer RNA and ribosomal RNA has been presented as evidence 
indicating that single-stranded RNA is an unlikely immunogenfor anti-DSRNA 
antibodies  (35). Present studies indicate that single-stranded polyribonucleo- 
tides, such as Poly A, which are more resistant to ribonuclease digestion, are 
reactive and that several types of antigens other than DSRNA  are potential 
immunogens. 
Antibodies  reactive  with  the  special  ribonucleoprotein  obtained  from  a 
phosphate-buffer  extract  of  nuclei  showed  no  cross-reactions  with  NDNA, 
SDNA,  DSRNA,  or  polyribonucleotides.  The  antigen  here  is  sensitive  to 
ribonuclease.  The  antibodies  involved  are  also  reactive  with  cytoplasmic 
ribosomes, and these relationships are currently under study. 
In  order  to  obtain  further  evidence concerning the  role  of  these  various 
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obtained from 25 patients with SLE followed for periods of 6 months to 4 yr. 
Three general conclusions could be derived from the data obtained from those 
experiments. Firstly, anti-NDNA antibodies were closely related to episodes of 
active disease in most cases. However, three of the 25 patients with classical 
SLE did not have anti-NDNA antibodies, although multiple episodes of clinical 
activity were observed. This would appear to indicate that this system is not 
necessarily involved in the mediation of tissue lesions in all instances.  One of 
these patients without anti-NDNA, SDNA, or DSRNA antibodies had several 
episodes of severe nephritis which were associated with  the appearance of a 
rheumatoid  factor  containing  cryoglobulin and  a  Clq  precipitin reaction in 
serum,  implicating  an  independent  antigen-antibody  system  in  this  patient 
(36,  37).  Secondly,  titers  of  antibodies  reactive with  SDNA  and  polyribo- 
nucleotides were frequently elevated during periods of clinical exacerbation in 
association with anti-NDNA  antibodies. They were also found to rise during 
periods when the patients were clinically inactive in contrast to anti-NDNA 
antibodies. Thirdly, titers of antibodies to ribonucleoprotein did not appear to 
fluctuate markedly and were not associated with disease activity. The majority 
of patients either exhibited elevated titers of this antibody in all sera or showed 
a  complete  absence  throughout  their  course,  although  occasional  patients 
showed peaks of activity indicating that  this antigen-antibody system is less 
frequently involved in complex formation. 
The variability in the types of antibodies associated with episodes of disease 
activity suggests that several types of immune complexes may be involved in the 
renal lesions. The results of fluorescent antibody studies of glomeruli showing 
deposition of native DNA (24), DNA with single-stranded determinants (38), 
and rheumatoid factor (36)  also suggest the heterogeneous nature of the im- 
mune complex deposits.  Furthermore,  elution studies indicate that  although 
antibodies to NDNA predominate, other types of anti-nuclear antibodies are 
concentrated in glomeruli,  and  in  several cases  anti-NDNA  antibodies  were 
not found in glomerular eluates. 
Previous studies  on  the  incidence of antibodies  to NDNA  and  SDNA  in 
various diseases indicated that  antibodies  to NDNA  were mainly limited  to 
patients with SLE (8). These studies were extended to include antibodies re- 
active with  DSRNA  and  nuclear  ribonucleoprotein. Antibodies  to  DSRNA 
were found in SLE and in low incidence in several other diseases, following a 
distribution similar to that of anti-SDNA  antibodies. In contrast,  antibodies 
to ribonucleoprotein were mainly limited to patients with SLE and other con- 
nective tissue disorders. Therefore, antibodies to NDNA and ribonucleoprotein 
have a  restricted distribution, whereas,  antibodies to polyribonucleotides and 
single stranded deoxyribonucleotides have a more widespread distribution in a 
variety of diseases where evidence of tissue injury exists. The results of these 
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SLE sera, suggest that SDNA is probably a major immunogen in man,  which 
may be responsible for a variety of anti-polynucleotide antibodies in SLE and 
other diseases. 
SUMMARY AND  CONCLIYSlONS 
The specificities of anti-polynucleotide antibodies found in human sera were 
studied using several immunological procedures. Anti-native DNA  (NDNA) 
antibodies and certain anti-double-stranded RNA  (DSRNA)  antibodies were 
found to react with single-stranded DNA (SDNA), and anti-NDNA antibodies 
were observed to react more avidly with SDNA than with NDNA in most sera 
tested. Antibodies to NDNA showed no preferential reactivity with NDNA or 
SDNA derived from mammalian tissue, bacterial, or viral sources. Precipitating 
antibodies reactive with individual bases, with common determinants of bases, 
and with common determinants of SDNA and NDNA were detected utilizing 
synthetic polydeoxyribonucleotides. Antibodies to DSRNA were also hetero- 
geneous and reactive with both Poly A. Poly U and Poly I. Poly C in addition 
to reactivity with Poly A and SDNA. In contrast, antibodies to a ribonucleo- 
protein determined by hemagglutination and by precipitation showed no reac- 
tion with NDNA, SDNA, or DSRNA. 
Serial  studies  of  serum  specimens  from  patients  with  systemic  lupus 
erythematosus (SLE) indicated that anti-NDNA antibodies were closely asso- 
ciated with  disease activity. Titers of antibodies to SDNA  or DSRNA  were 
also frequently increased during  these periods but in addition showed peaks 
during  quiescent  periods.  Anti-NDNA  antibodies  were  detected  in  most 
patients' sera at sometime during the course of the disease. Three patients were 
observed with active SLE, who did not develop anti-NDNA antibodies, even 
in the presence of severe renal disease. Evidence that other antigen-antibody 
systems may also play a role in the pathogenesis of the renal disease was partic- 
ularly apparent in these patients. Anti-ribonucleoprotein antibodies were not 
well  correlated with  the  peaks  of  antibody activity of other  polynucleotide 
antibodies,  suggesting  that  an  independent  immunogen  was  responsible  for 
induction of these antibodies. 
The close association of certain populations of anti-polynucleotide antibodies 
during  the  course  of  active  SLE,  the  presence  of  cross-reacting  antigenic 
determinants  of  SDNA,  NDNA,  and  DSRNA,  the  preferential  avidity  of 
anti-NDNA  antibodies for SDNA,  and  the frequent increase of anti-SDNA 
antibodies in SLE and other diseases associated with active tissue destruction 
suggest that SDNA is a ubiquitous antigen that may stimulate the formation 
of antibodies reactive with a variety of polynucleotides. 
The authors are gratefully indebted to Miss  Lydia Legrand for her excellent technical 
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